Health Progress In Eastern germany

4 September 1994

German parliamentary Health Secretary Sabine bergmann-Pohl has said that eastern German health treatment now matches that of western Germany, although eastern hospitals continue to give grounds for concern. While equipment has been considerably improved in recent years, the condition of many of the buildings in which clinics are housed is poor compared with those in western Germany.

Ms bergmann-Pohl says 10 more years are needed before the gap can be closed, with an estimated investment requirement of 20 billion Deutschemarks ($12.8 billion). Current federal investment in eastern German hospitals is running at 700 million marks ($450.8 million) a year.

The position of the eastern German health funds has improved, according to Ms Bergmann-Pohl; they posted a surplus of 1.3 billion marks ($837.3 million) in 1993, with spending on health services rising 10.1% and income increasing 16.5%. She added that in many areas western german levels of care have been achieved in the eastern states.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight